DK1362052T3 - Inhibitorer af cruzipain og andre cysteinproteaser - Google Patents
Inhibitorer af cruzipain og andre cysteinproteaserInfo
- Publication number
- DK1362052T3 DK1362052T3 DK02732145T DK02732145T DK1362052T3 DK 1362052 T3 DK1362052 T3 DK 1362052T3 DK 02732145 T DK02732145 T DK 02732145T DK 02732145 T DK02732145 T DK 02732145T DK 1362052 T3 DK1362052 T3 DK 1362052T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitors
- cruzipain
- cysteine proteases
- general formula
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0101179A GB0101179D0 (en) | 2001-01-17 | 2001-01-17 | Biologically active compounds |
| US27535901P | 2001-03-13 | 2001-03-13 | |
| PCT/GB2002/000184 WO2002057270A1 (en) | 2001-01-17 | 2002-01-17 | Inhibitors of cruzipain and other cysteine proteases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1362052T3 true DK1362052T3 (da) | 2007-07-09 |
Family
ID=26245571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02732145T DK1362052T3 (da) | 2001-01-17 | 2002-01-17 | Inhibitorer af cruzipain og andre cysteinproteaser |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7425562B2 (no) |
| EP (1) | EP1362052B1 (no) |
| JP (1) | JP4608183B2 (no) |
| KR (1) | KR100860067B1 (no) |
| CN (1) | CN1269822C (no) |
| AT (1) | ATE356130T1 (no) |
| AU (1) | AU2002219397B2 (no) |
| BR (1) | BR0206501A (no) |
| CA (1) | CA2436462C (no) |
| CY (1) | CY1106640T1 (no) |
| DE (1) | DE60218633T2 (no) |
| DK (1) | DK1362052T3 (no) |
| ES (1) | ES2281516T3 (no) |
| HK (1) | HK1060729A1 (no) |
| IL (2) | IL156774A0 (no) |
| MX (1) | MXPA03006224A (no) |
| NO (1) | NO328208B1 (no) |
| NZ (1) | NZ526913A (no) |
| PT (1) | PT1362052E (no) |
| RU (1) | RU2329266C2 (no) |
| WO (1) | WO2002057270A1 (no) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7064123B1 (en) | 2000-12-22 | 2006-06-20 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
| US7030116B2 (en) | 2000-12-22 | 2006-04-18 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
| IL160819A0 (en) | 2001-09-14 | 2004-08-31 | Aventis Pharma Inc | Novel compounds and compositions as cathepsin inhibitors |
| US6977256B2 (en) | 2001-11-14 | 2005-12-20 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin S inhibitors |
| BR0312662A (pt) * | 2002-07-16 | 2005-05-03 | Amura Therapeutics Ltd | Compostos biologicamente ativos |
| US7399765B2 (en) * | 2003-09-19 | 2008-07-15 | Abbott Laboratories | Substituted diazabicycloalkane derivatives |
| ATE461200T1 (de) * | 2004-01-08 | 2010-04-15 | Medivir Ab | Inhibitoren von cysteinprotease |
| JP2005350417A (ja) * | 2004-06-11 | 2005-12-22 | Dai Ichi Seiyaku Co Ltd | 還元的エーテル化法を用いたピロリジン誘導体の製造法 |
| EP1865940B1 (en) * | 2005-03-21 | 2013-02-13 | Virobay, Inc. | Alpha ketoamide compounds as cysteine protease inhibitors |
| GB0513839D0 (en) * | 2005-07-07 | 2005-08-10 | Medivir Ab | Cysteine protease inhibitors |
| GB0513840D0 (en) * | 2005-07-07 | 2005-08-10 | Medivir Ab | Cysteine protease inhibitors |
| GB0614046D0 (en) | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614037D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614042D0 (en) | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614044D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614073D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614052D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| GB0614053D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
| WO2008114054A1 (en) * | 2007-03-19 | 2008-09-25 | Medivir Ab | Protease inhibitors |
| US7893067B2 (en) | 2007-06-27 | 2011-02-22 | Medivir Ab | Cysteine protease inhibitors |
| WO2009087379A2 (en) * | 2008-01-09 | 2009-07-16 | Amura Therapeutics Limited | Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases |
| GB0804702D0 (en) | 2008-03-13 | 2008-04-16 | Amura Therapeutics Ltd | Compounds |
| GB0804701D0 (en) | 2008-03-13 | 2008-04-16 | Amura Therapeutics Ltd | Compounds |
| US9409880B2 (en) | 2011-01-20 | 2016-08-09 | The Regents Of The University Of Colorado, A Body Corporate | Modulators of TLR3/dsRNA complex and uses thereof |
| DK2891492T3 (da) | 2012-08-30 | 2022-11-21 | Univ Tokyo | Endoparasit kontrol middel |
| CN106279188A (zh) * | 2016-07-21 | 2017-01-04 | 青岛科技大学 | 一种多取代呋喃并[2,3‑b]吡咯衍生物的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3652574A (en) * | 1970-04-01 | 1972-03-28 | Abbott Lab | Certain 1 2 3 4 - tetrahydro-5h-pyrido (4 3-b)indoles and the corresponding 1 2 3 4-tetrahydro-9h-pyrido(3 4-b)indoles and derivatives thereof |
| DZ2285A1 (fr) | 1996-08-08 | 2002-12-25 | Smithkline Beecham Corp | Inhibiteurs de protéase de la cystéine. |
| JP2000517319A (ja) | 1996-08-28 | 2000-12-26 | スミスクライン・ビーチャム・コーポレイション | システインプロテアーゼのインヒビター |
| NZ335583A (en) | 1996-12-23 | 2001-03-30 | Lilly Co Eli | Cycloalkyl, lactam, lactone and analogs, and pharmaceutical compositions |
| AR013079A1 (es) | 1997-05-06 | 2000-12-13 | Smithkline Beecham Corp | Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios |
| MA26618A1 (fr) | 1998-04-09 | 2004-12-20 | Smithkline Beecham Corp | Composes et compositions pharmaceutiques pour le traitement du paludisme |
| CO5150165A1 (es) | 1998-11-13 | 2002-04-29 | Smithkline Beecham Plc | Inhibidores de proteasa: tipo catepsina k |
| GB9911417D0 (en) * | 1999-05-18 | 1999-07-14 | Peptide Therapeutics Ltd | Furanone derivatives as inhibitors of cathepsin s |
| WO2002040462A2 (en) | 2000-11-17 | 2002-05-23 | Medivir Uk Limited | Cysteine protease inhibitors |
| US7064123B1 (en) | 2000-12-22 | 2006-06-20 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
-
2002
- 2002-01-17 MX MXPA03006224A patent/MXPA03006224A/es active IP Right Grant
- 2002-01-17 US US10/466,384 patent/US7425562B2/en not_active Expired - Fee Related
- 2002-01-17 DK DK02732145T patent/DK1362052T3/da active
- 2002-01-17 NZ NZ526913A patent/NZ526913A/xx not_active IP Right Cessation
- 2002-01-17 KR KR1020037009524A patent/KR100860067B1/ko not_active IP Right Cessation
- 2002-01-17 AT AT02732145T patent/ATE356130T1/de active
- 2002-01-17 WO PCT/GB2002/000184 patent/WO2002057270A1/en active IP Right Grant
- 2002-01-17 IL IL15677402A patent/IL156774A0/xx active IP Right Grant
- 2002-01-17 CA CA2436462A patent/CA2436462C/en not_active Expired - Fee Related
- 2002-01-17 RU RU2003125270/04A patent/RU2329266C2/ru not_active IP Right Cessation
- 2002-01-17 AU AU2002219397A patent/AU2002219397B2/en not_active Ceased
- 2002-01-17 JP JP2002557947A patent/JP4608183B2/ja not_active Expired - Fee Related
- 2002-01-17 PT PT02732145T patent/PT1362052E/pt unknown
- 2002-01-17 ES ES02732145T patent/ES2281516T3/es not_active Expired - Lifetime
- 2002-01-17 CN CNB028038142A patent/CN1269822C/zh not_active Expired - Fee Related
- 2002-01-17 DE DE60218633T patent/DE60218633T2/de not_active Expired - Lifetime
- 2002-01-17 EP EP02732145A patent/EP1362052B1/en not_active Expired - Lifetime
- 2002-01-17 BR BR0206501-0A patent/BR0206501A/pt not_active IP Right Cessation
-
2003
- 2003-07-03 IL IL156774A patent/IL156774A/en not_active IP Right Cessation
- 2003-07-16 NO NO20033220A patent/NO328208B1/no not_active IP Right Cessation
-
2004
- 2004-05-14 HK HK04103421A patent/HK1060729A1/xx not_active IP Right Cessation
-
2007
- 2007-06-04 CY CY20071100742T patent/CY1106640T1/el unknown
-
2008
- 2008-09-15 US US12/211,069 patent/US20090247471A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT1362052E (pt) | 2007-04-30 |
| US20090247471A1 (en) | 2009-10-01 |
| BR0206501A (pt) | 2004-01-13 |
| RU2003125270A (ru) | 2005-02-20 |
| MXPA03006224A (es) | 2004-10-15 |
| HK1060729A1 (en) | 2004-08-20 |
| AU2002219397B2 (en) | 2008-02-14 |
| EP1362052A1 (en) | 2003-11-19 |
| NZ526913A (en) | 2004-12-24 |
| DE60218633D1 (de) | 2007-04-19 |
| CA2436462A1 (en) | 2002-07-25 |
| WO2002057270A1 (en) | 2002-07-25 |
| ES2281516T3 (es) | 2007-10-01 |
| CN1486320A (zh) | 2004-03-31 |
| IL156774A (en) | 2008-08-07 |
| US20040138250A1 (en) | 2004-07-15 |
| DE60218633T2 (de) | 2008-02-21 |
| NO328208B1 (no) | 2010-01-11 |
| JP4608183B2 (ja) | 2011-01-05 |
| NO20033220D0 (no) | 2003-07-16 |
| NO20033220L (no) | 2003-09-17 |
| KR100860067B1 (ko) | 2008-09-24 |
| US7425562B2 (en) | 2008-09-16 |
| RU2329266C2 (ru) | 2008-07-20 |
| ATE356130T1 (de) | 2007-03-15 |
| CY1106640T1 (el) | 2012-01-25 |
| JP2004518674A (ja) | 2004-06-24 |
| CA2436462C (en) | 2011-07-05 |
| KR20030075161A (ko) | 2003-09-22 |
| EP1362052B1 (en) | 2007-03-07 |
| CN1269822C (zh) | 2006-08-16 |
| IL156774A0 (en) | 2004-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1362052T3 (da) | Inhibitorer af cruzipain og andre cysteinproteaser | |
| EA200300017A1 (ru) | Ингибиторы серинпротеазы | |
| TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
| ATE445400T1 (de) | Hydantion-derivate als hemmer von matrix- metalloproteinasen | |
| CY1114554T1 (el) | Ινδαζολια, βενζοτριαζολια και ν-αναλογα αυτων ως αναστολεις p38 κινασης | |
| ECSP044992A (es) | Inhibidores de la alquín-aril fosfodiesterasa-4 | |
| SE0201976D0 (sv) | Novel compounds | |
| IS6957A (is) | Tatrat sölt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9,-pentaen og lyfjafræðilegar samsetningar af þeim | |
| DK1569929T3 (da) | Forbindelser og fremgangsmåder til behandling eller forebyggelse af flavi-virusinfektioner | |
| EA200301100A1 (ru) | Новые фталазиноны | |
| CY1108446T1 (el) | Μη νευροτοξικοι παραγοντες ενεργοποιησης πλασμινογονου για την αντιμετωπιση αποπληξιας | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| DE60310767D1 (de) | PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN | |
| SE0003476D0 (sv) | Compounds | |
| DE60202669D1 (de) | 6-phenylbenzonaphthyidine | |
| ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
| DE60033809D1 (de) | Inhibitoren von metalloproteinasen | |
| EA200301101A1 (ru) | Производные пиперазина и их применение в качестве ингибиторов pde4 | |
| WO2002057246A3 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
| DE60228134D1 (de) | Substituierte hydrazone als hemmer von cyclooxygenase-2 | |
| WO2002057248A3 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| ATE348803T1 (de) | Tryptase-inhibitoren | |
| DK1358182T3 (da) | Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer |